HHS sends a plan letting pharmacies compound peptides like BPC-157 to the White House
Two people familiar with the policy tell AP it would let compounders make some popular peptides without FDA enforcement, though FDA staff scientists say none are proven safe.
Recap by typeshit. Full story at The Baltimore Sun.